Borstkanker Onderzoek Groep

This study is testing if adding a drug called alpelisib to the standard hormone therapy fulvestrant can help control advanced breast cancer that has started to grow again while on fulvestrant alone. It is for 130 adults with a specific type of breast cancer (hormone-receptor posi…

This study aims to find the best order for giving two types of treatments to women with advanced breast cancer that is fueled by hormones. It compares starting with a strong combination of hormone therapy plus a targeted drug, versus saving that strong combination for later. The …

This study is testing if the drug trifluridine/tipiracil can help control advanced breast cancer that has grown after standard chemotherapy. It is for women with a specific type of breast cancer (ER-positive, HER2-negative) that has spread. The main goal is to see if the treatmen…

This study is testing a personalized approach to chemotherapy for HER2-positive breast cancer. It aims to see if doctors can safely give fewer chemotherapy cycles to patients who show a strong, early response to treatment on an MRI scan. The goal is to reduce side effects while s…

This study is testing if a combination of two pills (ribociclib and letrozole) can work as well as standard chemotherapy when given before surgery for certain types of breast cancer. It involves 100 postmenopausal women with hormone-sensitive, HER2-negative breast cancer. Doctors…